Quarterly Medical Policy Updates Effective Oct. 1, 2026
Effective Date: Oct. 1, 2026
Health Plans Affected: Advantage MD, Employer Health Programs (EHP), Priority Partners, US Family Health Plan (USFHP)
Type of Change: Medical Policy
Explanation of Change:
The Johns Hopkins Health Plans Medical Policy Advisory Committee (MPAC) has approved the following updates to our medical policies. These changes will go into effect Oct. 1, 2026.
View the Medical Policy Updates
Changes this quarter include:
- Revised
- CMS21.01 - Neuromodulation for Bladder and Bowel Dysfunction (Formerly: “Neuromodulation for Overactive Bladder, Urinary Retention and Fecal Incontinence)
- CMS11.02 - Preventive Health Guidelines
- CMS 16.02 - Treatment for Skin Conditions
- CMS19.07 - Stretching Devices for the Treatment of Joint Stiffness & Contracture
- CMS23.07 - Infertility Treatment & Fertility Preservation
- CMS21.01 - Neuromodulation for Bladder and Bowel Dysfunction (Formerly: “Neuromodulation for Overactive Bladder, Urinary Retention and Fecal Incontinence)
- Retired
- CMS03.08 - Panniculectomy
- Focused Updates
- CMS24.26 - Cell and Gene Therapy Access Model
- CMS23.05 - Site of Service- Outpatient Surgical Procedures
- CMS24.26 - Cell and Gene Therapy Access Model
To view the full descriptions of these policies, please visit the Medical Policies section of the Johns Hopkins Health Plans website on or after the effective date or call Provider Relations at 888-895-4998 (option 4).